Baxter Aims to Use Microsphere Tech to Deliver siRNAs Targeting Herpes Virus

Baxter is conducting the work in collaboration with Judy Lieberman, a researcher at Harvard Medical School’s Immune Disease Institute, and expects that a microsphere technology that has shown promise with antisense oligos may be used to deliver siRNAs.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.